Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katerina Geronatsiou"'
Autor:
Alexandra Kalogeraki, Dimitrios Tamiolakis, Thomas Tsagatakis, Katerina Geronatsiou, Vrettos Haniotis, Maria Kafoussi
Publikováno v:
Acta Médica Portuguesa, Vol 26, Iss 4 (2013)
Introduction: Eccrine porocarcinoma is an uncommon malignant adnexal tumor of the skin. Eccrine porocarcinoma is an adenocarcinoma of the eccrine sweat gland with a propensity to recur locally and gives metastases to regional lymph nodes. This paper
Externí odkaz:
https://doaj.org/article/c95817cda37148dbb4ef59eba85e13f6
Autor:
George Adonakis, Helen P. Kourea, George Decavalas, Kostas Antonopoulos, Katerina Geronatsiou, Marinos Nikolaou
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 39:727-732
We report a rare case of spontaneous uterine rupture of an unscarred uterus caused by adenomyosis in the early third trimester. A 33-year-old primigravid woman was referred to our department because of severe acute abdominal pain and signs and sympto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81cd25f5df999da6bce3187c38f18fbf
https://doi.org/10.1111/j.1447-0756.2012.02042.x
https://doi.org/10.1111/j.1447-0756.2012.02042.x
Autor:
Helen A. Papadaki, Dimitrios Siamblis, Konstantinos Katsanos, Evangelos Liatsikos, Dimitrios Karnabatidis, Athanasios Diamantopoulos, George Loudos, Iason Kyriazis, Nikos E. Tsopanoglou, Katerina Geronatsiou, George C. Kagadis
Publikováno v:
American Journal of Nephrology. 36:278-286
Background/Aims: Parstatin is a 41-mer peptide formed by proteolytic cleavage on activation of the protease-activated receptor 1. Parstatin was recently found to be cardioprotective against myocardial ischemia/reperfusion (IR) injury. In the present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fa60039d4086cab765c18c77d605aee
https://doi.org/10.1159/000341871
https://doi.org/10.1159/000341871
Autor:
Iason Kyriazis, Panagiotis Kallidonis, Odysseas Andrikopoulos, Nicolaos Tsopanoglou, Katerina Geronatsiou, Helen Papadaki, Despoina Liourdi, Evangelos Liatsikos
Publikováno v:
Journal of Urology. 185
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adeb107b906d31f07ba6af1dd233ce97
https://doi.org/10.1016/j.juro.2011.02.478
https://doi.org/10.1016/j.juro.2011.02.478
Autor:
Ji kui Shen, Sotirios P. Gartaganis, Hu Huang, Stanley A. Vinores, Xiufeng Zhong, Michael E. Maragoudakis, Panagiotis Vasilakis, Nikos E. Tsopanoglou, Katerina Geronatsiou, Helen A. Papadaki
Parstatin is a 41-mer peptide formed by proteolytic cleavage on activation of the PAR1 receptor. The authors recently showed that parstatin is a potent inhibitor of angiogenesis. The purpose of the present study was to evaluate the therapeutic effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7793130a09742098c9479b640ed92bbf
https://europepmc.org/articles/PMC3061514/
https://europepmc.org/articles/PMC3061514/
